首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1009107篇
  免费   67752篇
  国内免费   2941篇
耳鼻咽喉   13970篇
儿科学   31963篇
妇产科学   28829篇
基础医学   141574篇
口腔科学   27404篇
临床医学   82576篇
内科学   206911篇
皮肤病学   21967篇
神经病学   79862篇
特种医学   39127篇
外国民族医学   354篇
外科学   155359篇
综合类   20684篇
现状与发展   1篇
一般理论   274篇
预防医学   76403篇
眼科学   22548篇
药学   72414篇
  6篇
中国医学   2659篇
肿瘤学   54915篇
  2021年   8191篇
  2019年   8749篇
  2018年   12804篇
  2017年   9515篇
  2016年   9920篇
  2015年   11382篇
  2014年   15329篇
  2013年   23663篇
  2012年   32995篇
  2011年   34704篇
  2010年   20504篇
  2009年   18756篇
  2008年   32004篇
  2007年   33899篇
  2006年   33863篇
  2005年   33362篇
  2004年   31620篇
  2003年   30404篇
  2002年   29756篇
  2001年   44364篇
  2000年   45636篇
  1999年   38825篇
  1998年   10610篇
  1997年   9608篇
  1996年   9511篇
  1995年   8792篇
  1994年   8405篇
  1992年   29512篇
  1991年   28194篇
  1990年   27577篇
  1989年   26414篇
  1988年   24594篇
  1987年   24130篇
  1986年   23163篇
  1985年   22061篇
  1984年   16460篇
  1983年   13989篇
  1982年   8343篇
  1979年   15252篇
  1978年   10597篇
  1977年   8966篇
  1976年   8504篇
  1975年   9323篇
  1974年   11247篇
  1973年   10711篇
  1972年   10128篇
  1971年   9308篇
  1970年   9035篇
  1969年   8457篇
  1968年   8094篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
Journal of Digital Imaging - Vertebral Compression Fracture (VCF) occurs when the vertebral body partially collapses under the action of compressive forces. Non-traumatic VCFs can be secondary to...  相似文献   
62.
63.
64.
This study aimed at deriving occupational thresholds of toxicological concern for inhalation exposure to systemically-acting organic chemicals using predicted internal doses. The latter were also used to evaluate the quantitative relationship between occupational exposure limit and internal dose. Three internal dose measures were identified for investigation: (i) the daily area under the venous blood concentration vs. time curve, (ii) the daily rate of the amount of parent chemical metabolized, and (iii) the maximum venous blood concentration at the end of an 8-hr work shift. A dataset of 276 organic chemicals with 8-hr threshold limit values-time-weighted average was compiled along with their molecular structure and Cramer classes (Class I: low toxicity, Class II: intermediate toxicity, Class III: suggestive of significant toxicity). Using a human physiologically-based pharmacokinetic model, the three identified dose metrics were predicted for an 8-hr occupational inhalation exposure to the threshold limit value for each chemical. Distributional analyses of the predicted dose metrics were performed to identify the percentile values corresponding to the occupational thresholds of toxicological concern. Also, simple linear regression analyses were performed to evaluate the relationship between the 8-hr threshold limit value and each of the predicted dose metrics, respectively. No threshold of toxicological concern could be derived for class II due to few chemicals. Based on the daily rate of the amount of parent chemical metabolized, the proposed internal dose-based occupational thresholds of toxicological concern were 5.61?×?10?2 and 9?×?10?4 mmol/d at the 10th percentile level for classes I and III, respectively, while they were 4.55?×?10?1 and 8.5?×?10?3 mmol/d at the 25th percentile level. Even though high and significant correlations were observed between the 8-hr threshold limit values and the predicted dose metrics, the one with the rate of the amount of chemical metabolized was remarkable regardless of the Cramer class (r2 = 0.81; n = 276). The proposed internal dose-based occupational thresholds of toxicological concern are potentially useful for screening-level assessments as well as prioritization within an integrated occupational risk assessment framework.  相似文献   
65.
66.
67.
European Journal of Clinical Microbiology & Infectious Diseases - We compared the performance of an in-house-developed flow cytometry assay for intracellular cytokine staining (FC-ICS) and a...  相似文献   
68.
69.
70.

Background

The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.

Methods

Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.

Results

Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.

Conclusions

No safety concerns arose, supporting the favorable benefit-risk profile of RZV.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号